Net Income Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual net income in 2023 was 43.67 Million TWD , down -41.64% from previous year.
Abnova (Taiwan) Corporation's latest quarterly net income in 2024 Q1 was 26.7 Million TWD , up 147.56% from previous quarter.
Abnova (Taiwan) Corporation reported an annual net income of 74.84 Million TWD in 2022, up 163.82% from previous year.
Abnova (Taiwan) Corporation reported an annual net income of 28.36 Million TWD in 2021, down -22.33% from previous year.
Abnova (Taiwan) Corporation reported a quarterly net income of 26.7 Million TWD for 2024 Q1, up 147.56% from previous quarter.
Abnova (Taiwan) Corporation reported a quarterly net income of 10.15 Million TWD for 2023 Q3, down -15.7% from previous quarter.

Annual Net Income Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Net Income of Abnova (Taiwan) Corporation (2023 - 2009)

Year	Net Income	Net Income Growth
2023	43.67 Million TWD	-41.64%
2022	74.84 Million TWD	163.82%
2021	28.36 Million TWD	-22.33%
2020	36.52 Million TWD	1019.4%
2019	3.26 Million TWD	-92.92%
2018	46.11 Million TWD	-21.79%
2017	58.96 Million TWD	10.14%
2016	53.53 Million TWD	19.21%
2015	44.91 Million TWD	-31.58%
2014	65.64 Million TWD	-9.95%
2013	72.89 Million TWD	-5.13%
2012	76.83 Million TWD	-35.9%
2011	119.86 Million TWD	-19.58%
2010	149.04 Million TWD	49.71%
2009	99.55 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	18.29 Million TWD	-31.49%
2024 Q1	26.7 Million TWD	147.56%
2023 Q3	10.15 Million TWD	-15.7%
2023 Q1	10.69 Million TWD	-9.49%
2023 FY	43.67 Million TWD	-41.64%
2023 Q2	12.04 Million TWD	12.59%
2023 Q4	10.78 Million TWD	6.25%
2022 FY	74.84 Million TWD	163.82%
2022 Q2	18.86 Million TWD	9.1%
2022 Q3	26.87 Million TWD	42.46%
2022 Q4	11.81 Million TWD	-56.02%
2022 Q1	17.29 Million TWD	1313.33%
2021 Q2	6.91 Million TWD	-29.14%
2021 Q1	9.76 Million TWD	0.01%
2021 Q4	-1.42 Million TWD	-110.87%
2021 FY	28.36 Million TWD	-22.33%
2021 Q3	13.11 Million TWD	89.61%
2020 Q3	14.94 Million TWD	262.62%
2020 FY	36.52 Million TWD	1019.4%
2020 Q1	7.69 Million TWD	269.11%
2020 Q2	4.12 Million TWD	-46.44%
2020 Q4	9.76 Million TWD	-34.7%
2019 Q3	544 Thousand TWD	-78.27%
2019 FY	3.26 Million TWD	-92.92%
2019 Q1	-1.86 Million TWD	-112.39%
2019 Q4	2.08 Million TWD	283.27%
2019 Q2	2.5 Million TWD	233.92%
2018 Q3	9.86 Million TWD	-23.72%
2018 Q2	12.93 Million TWD	56.99%
2018 FY	46.11 Million TWD	-21.79%
2018 Q4	15.08 Million TWD	52.99%
2018 Q1	8.23 Million TWD	-38.06%
2017 Q2	17.02 Million TWD	43.6%
2017 Q4	13.29 Million TWD	-20.78%
2017 Q1	11.85 Million TWD	-31.65%
2017 FY	58.96 Million TWD	10.14%
2017 Q3	16.78 Million TWD	-1.42%
2016 Q2	13.21 Million TWD	-9.85%
2016 FY	53.53 Million TWD	19.21%
2016 Q4	17.34 Million TWD	108.6%
2016 Q3	8.31 Million TWD	-37.08%
2016 Q1	14.66 Million TWD	44.21%
2015 FY	44.91 Million TWD	-31.58%
2015 Q4	10.16 Million TWD	16.21%
2015 Q2	25.4 Million TWD	4198.82%
2015 Q3	8.74 Million TWD	-65.57%
2015 Q1	591 Thousand TWD	-97.46%
2014 Q3	16.39 Million TWD	33.78%
2014 FY	65.64 Million TWD	-9.95%
2014 Q4	23.26 Million TWD	41.89%
2014 Q2	12.25 Million TWD	-10.79%
2014 Q1	13.73 Million TWD	8.3%
2013 Q3	15.51 Million TWD	-21.77%
2013 Q4	12.68 Million TWD	-18.24%
2013 FY	72.89 Million TWD	-5.13%
2013 Q1	24.87 Million TWD	51.9%
2013 Q2	19.83 Million TWD	-20.27%
2012 Q3	18.85 Million TWD	20.49%
2012 FY	76.83 Million TWD	-35.9%
2012 Q4	16.37 Million TWD	-13.16%
2012 Q2	15.64 Million TWD	-42.81%
2012 Q1	27.36 Million TWD	-5.91%
2011 Q3	28.31 Million TWD	21.56%
2011 Q4	29.07 Million TWD	2.7%
2011 FY	119.86 Million TWD	-19.58%
2011 Q1	39.17 Million TWD	95.71%
2011 Q2	23.29 Million TWD	-40.55%
2010 Q1	42.42 Million TWD	0.0%
2010 FY	149.04 Million TWD	49.71%
2010 Q3	40.91 Million TWD	-10.47%
2010 Q4	20.01 Million TWD	-51.07%
2010 Q2	45.69 Million TWD	7.72%
2009 FY	99.55 Million TWD	0.0%

Peer Net Income Comparison of Abnova (Taiwan) Corporation

Name	Net Income	Net Income Difference
Apex Biotechnology Corp.	115.78 Million TWD	62.276%
Sinphar Pharmaceutical Co.,Ltd.	375.17 Million TWD	88.358%
Panion & Bf Biotech Inc.	77.21 Million TWD	43.436%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	264.9 Million TWD	83.512%
GenMont Biotech Incorporation	32.99 Million TWD	-32.394%
Adimmune Corporation	-639.89 Million TWD	106.826%
Tanvex BioPharma, Inc.	-2.13 Billion TWD	102.044%
Polaris Group	-1.57 Billion TWD	102.77%
Energenesis Biomedical CO.,LTD.	-260.38 Million TWD	116.775%
UnicoCell Biomed Co., Ltd.	-84.1 Million TWD	151.931%
PELL Bio-Med Technology Co. Ltd.	-398.75 Million TWD	110.954%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

Net Income Summary of Abnova (Taiwan) Corporation

Annual Net Income Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Net Income of Abnova (Taiwan) Corporation (2023 - 2009)

Peer Net Income Comparison of Abnova (Taiwan) Corporation